| scholarly article | Q13442814 |
| P50 | author | Shirzad Nasiri | Q61196972 |
| P2093 | author name string | Nasiri S | |
| P2860 | cites work | A randomized trial of washed red blood cell and platelet transfusions in adult acute leukemia [ISRCTN76536440] | Q24801336 |
| Activated platelets release two types of membrane vesicles: microvesicles by surface shedding and exosomes derived from exocytosis of multivesicular bodies and alpha-granules | Q29614240 | ||
| Infusible platelet membranes retain partial functionality of the platelet GPIb/IX/V receptor complex | Q31974821 | ||
| Reduction of blood loss by infusion of human platelets in a rabbit kidney injury model | Q33330387 | ||
| Infusible platelet membranes improve hemostasis in thrombocytopenic blood: experimental studies under flow conditions | Q33334113 | ||
| Platelet washing to prevent recurrent febrile reactions to leucocyte-reduced transfusions | Q33337118 | ||
| Novel treatment modalities: new platelet preparations and substitutes | Q33338937 | ||
| A method for evaluating the hemostatic effect of various agents in thrombocytopenic rats and mie. | Q33353303 | ||
| Fresh, Disintegrated Platelets in Radiation Thrombocytopenia: Correction of Prothrombin Consumption without Correction of Bleeding | Q33356441 | ||
| Effectiveness of transfusions of fresh and lyophilized platelets in controlling bleeding due to thrombocytopenia | Q33356457 | ||
| The functional integrity of platelets in volume-reduced platelet concentrates | Q33364264 | ||
| Clinical significance of platelet microparticles in autoimmune thrombocytopenias | Q33365864 | ||
| Evaluation of the transfusion effectiveness of various platelet concentrates by means of an in vitro perfusion technique | Q33388525 | ||
| The bleeding time does not predict surgical bleeding | Q33389395 | ||
| Effect of centrifugation on the storage properties of platelets | Q67964332 | ||
| Platelet membrane glycoprotein changes during the preparation and storage of platelet concentrates | Q68302488 | ||
| Platelet storage lesion: formation of platelet fragments with platelet factor 3 activity | Q68684503 | ||
| Activation of endothelial cells induces platelet thrombus formation on their matrix. Studies of new in vitro thrombosis model with low molecular weight heparin as anticoagulant | Q68697117 | ||
| Analysis of platelet factor 3 in platelet concentrates stored for transfusion | Q69708675 | ||
| Interaction of long-term stored platelets with vascular subendothelium | Q69727461 | ||
| Complement proteins C5b-9 cause release of membrane vesicles from the platelet surface that are enriched in the membrane receptor for coagulation factor Va and express prothrombinase activity | Q69843451 | ||
| Morphological changes associated with pH changes during storage of platelet concentrates in first-generation 3-day container | Q70039012 | ||
| Generation of prothrombin-converting activity and the exposure of phosphatidylserine at the outer surface of platelets | Q70284698 | ||
| Changes in membrane phospholipid distribution during platelet activation | Q70458101 | ||
| Evidence for appearance of "lysis independent" procoagulant activities in collagen or thrombin stimulated platelets | Q71016300 | ||
| On a possible interaction between ADP and mechanical stimulation in platelet activation | Q71341183 | ||
| Platelet concentrates promote procoagulant activity: evidence from experimental studies using a perfusion technique | Q71948209 | ||
| Activation in stored platelet concentrates: correlation between membrane expression of P‐selectin, glycoprotein IIb/IIIa, and beta‐ thromboglobulin release | Q72068375 | ||
| The Nature and Significance of Platelet Products in Human Plasma | Q72220665 | ||
| Control of the postirradiation hemorrhagic state by platelet transfusions | Q73174740 | ||
| Frozen platelets and platelet substitutes in transfusion medicine | Q73656652 | ||
| Stabilizing effects of caprylate and acetyltryptophanate on heat-induced aggregation of bovine serum albumin | Q73914999 | ||
| Summary of a workshop on in vivo efficacy of transfused platelet components and platelet substitutes | Q73919768 | ||
| Hemostasis in thrombocytopenic bleeding following infusion of stored, frozen platelets | Q74140137 | ||
| The preparation and clinical administration of lyophilized platelet material to children with acute leukemia and aplastic anemia | Q74258254 | ||
| Novel platelet products and substitutes | Q74796234 | ||
| Displacement of serotonin from tissues by a specific antimetabolite | Q74797992 | ||
| Leukocytes in blood transfusion: adverse effects and their prevention | Q77595734 | ||
| Biologic assay of a thrombosis-inducing activity in human serum | Q79300398 | ||
| Cytokine generation in stored platelet concentrate: comparison of two methods of preparation | Q79422818 | ||
| White blood cell fragments in platelet concentrates prepared by the platelet-rich plasma or buffy-coat methods | Q81722241 | ||
| Production and characterization of liquid-stored and lyophilized reconstituted human infusible platelet membranes | Q84453250 | ||
| Inactivation of hepatitis A variants during heat treatment (pasteurization) of human serum albumin | Q84595471 | ||
| Platelet membrane vesicles reduced microvascular bleeding times in thrombocytopenic rabbits | Q33456803 | ||
| Platelet membrane microparticles in blood bank fresh frozen plasma and cryoprecipitate | Q33459680 | ||
| Infusible platelet membrane microvesicles: a potential transfusion substitute for platelets | Q33496016 | ||
| The thrombocytopenic rabbit bleeding time model to evaluate the in vivo hemostatic efficacy of platelets and platelet substitutes | Q33499204 | ||
| In vitro evaluation of the hemostatic effectiveness of non viable platelet preparations: studies with frozen-thawed, sonicated or lyophilized platelets. | Q33500125 | ||
| Discontinuation of the bleeding time test without detectable adverse clinical impact | Q33953231 | ||
| An association between decreased cardiopulmonary complications (transfusion-related acute lung injury and transfusion-associated circulatory overload) and implementation of universal leukoreduction of blood transfusions | Q34148215 | ||
| Function and clinical significance of platelet-derived microparticles | Q34496416 | ||
| Microparticles in hemostasis and thrombosis. | Q35131040 | ||
| Contribution of perfusion techniques to the evaluation of the hemostatic effectiveness of platelet concentrates | Q35178373 | ||
| Bacterial contamination of blood components: risks, strategies, and regulation: joint ASH and AABB educational session in transfusion medicine | Q35591493 | ||
| The release of vesicles from platelets following adhesion to vessel walls in vitro | Q36130229 | ||
| Procoagulant microparticles: disrupting the vascular homeostasis equation? | Q36600785 | ||
| Pathogen inactivation: the definitive safeguard for the blood supply | Q36815115 | ||
| Platelet procoagulant activity: physiological significance and mechanisms of exposure | Q36928487 | ||
| Beyond hemostasis: the role of platelets in inflammation, malignancy and infection. | Q37184887 | ||
| Pathogen reduction of blood components | Q37207560 | ||
| Circulating tissue factor-exposing microparticles | Q37240172 | ||
| Analysis of tissue factor positive microparticles | Q37699798 | ||
| Immunomodulatory mediators in platelet transfusion reactions | Q37967329 | ||
| Platelet storage and transfusions: new concerns associated with an old therapy | Q38015853 | ||
| A critical reappraisal of the bleeding time | Q38143842 | ||
| New frontiers in transfusion biology: identification and significance of mediators of morbidity and mortality in stored red blood cells | Q38604097 | ||
| Platelet transfusion therapy: platelet concentrate preparation and storage. | Q39634225 | ||
| An overview of hemostasis | Q40766785 | ||
| Viral infectivity of albumin and plasma protein fraction | Q41248127 | ||
| Effects of storage on platelet reactivity to arterial subendothelium during blood flow | Q41689512 | ||
| Evaluation of lyophilized platelets as an infusible hemostatic agent in experimental non-compressible hemorrhage in swine | Q43298272 | ||
| Lysed platelets shorten the activated coagulation time (ACT) of heparinized blood | Q44297865 | ||
| Platelet microvesicles adhere to subendothelium and promote adhesion of platelets | Q44897189 | ||
| Post-transfusion recovery of function of 5-day stored platelet concentrates | Q44909703 | ||
| Assembly of the platelet prothrombinase complex is linked to vesiculation of the platelet plasma membrane. Studies in Scott syndrome: an isolated defect in platelet procoagulant activity | Q45209568 | ||
| Thrombosomes: a platelet‐derived hemostatic agent for control of noncompressible hemorrhage | Q45902625 | ||
| The phospholipid composition and cholesterol content of platelet-derived microparticles: a comparison with platelet membrane fractions | Q46855022 | ||
| The role of blood flow in platelet adhesion, fibrin deposition, and formation of mural thrombi | Q48007119 | ||
| Cell-derived microparticles in haemostasis and vascular medicine. | Q50616202 | ||
| Platelet microparticle membranes have 50- to 100-fold higher specific procoagulant activity than activated platelets | Q58487090 | ||
| Preparations of synthetic phospholipids promote procoagulant activity on damaged vessels: studies under flow conditions | Q61914701 | ||
| Vesiculation of platelets during in vitro aging | Q67681063 | ||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 337-342 | |
| P577 | publication date | 2013-05-14 | |
| P1433 | published in | Blood transfusion | Q26842792 |
| P1476 | title | Infusible platelet membrane as a platelet substitute for transfusion: an overview | |
| P478 | volume | 11 |
| Q47324534 | Biomaterials and Advanced Technologies for Hemostatic Management of Bleeding. |
| Q49958847 | Intravenous synthetic platelet (SynthoPlate) nanoconstructs reduce bleeding and improve 'golden hour' survival in a porcine model of traumatic arterial hemorrhage |
| Q88967545 | Targeted repair of heart injury by stem cells fused with platelet nanovesicles |
Search more.